{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:34:38Z","timestamp":1789043678230,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.chest.2020.03.035","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T19:23:04Z","timestamp":1585855384000},"page":"1218-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome"],"prefix":"10.1016","volume":"158","author":[{"given":"Sof\u00eda","family":"Romero-Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cano-Pumarega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Garc\u00eda-Borreguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2020.03.035_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jsmc.2015.05.017","article-title":"Restless legs syndrome\/Willis-Ekbom disease morbidity","volume":"10","author":"Stevens","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.chest.2020.03.035_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sleep.2017.06.023","article-title":"The urge to move and breathe\u2014the impact of obstructive sleep apnea syndrome treatment in patients with previously diagnosed, clinically significant restless legs syndrome","volume":"38","author":"Silva","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.0954-6820.1950.tb12291.x","article-title":"Restless legs: a report of 70 new cases","volume":"246","author":"Ekbom","year":"1950","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.chest.2020.03.035_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smrv.2011.05.002","article-title":"Epidemiology of restless legs syndrome: a synthesis of the literature","volume":"16","author":"Ohayon","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.chest.2020.03.035_bib5","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/mds.22274","article-title":"Prevalence of restless legs syndrome in a rural community in Japan","volume":"23","author":"Nomura","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib6","article-title":"Prevalence and risk factors of restless legs syndrome among Chinese adults in a rural community of Shanghai in China","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2020.03.035_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5664\/jcsm.1756","article-title":"Incidence of restless legs syndrome and its correlates","volume":"8","author":"Budhiraja","year":"2012","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archinte.164.2.196","article-title":"(2004). Sex and the risk of restless legs syndrome in the general population","volume":"164","author":"Berger","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.chest.2020.03.035_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.smrv.2017.10.003","article-title":"(2018). Prevalence of restless legs syndrome during pregnancy: a systematic review and meta-analysis","volume":"40","author":"Chen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.chest.2020.03.035_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2006-2767","article-title":"Restless legs syndrome: prevalence and impact in children and adolescents: the Peds REST study","volume":"120","author":"Picchietti","year":"2007","journal-title":"Pediatrics"},{"issue":"Suppl","key":"10.1016\/j.chest.2020.03.035_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1389-9457(02)00140-5","article-title":"Family history study of the restless legs syndrome","volume":"3","author":"Allen","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","article-title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","volume":"16","author":"Schormair","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/420772","article-title":"Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p","volume":"74","author":"Chen","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.chest.2020.03.035_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/393ad2d3-df4f-4770-87bc-00bfabf79362","article-title":"Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1","volume":"7","author":"Winkelmann","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.chest.2020.03.035_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ng.190","article-title":"PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome","volume":"40","author":"Schormair","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.chest.2020.03.035_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng2099","article-title":"Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions","volume":"39","author":"Winkelmann","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.chest.2020.03.035_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archneur.62.4.591","article-title":"Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity","volume":"62","author":"Desautels","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/awg137","article-title":"Autosomal dominant restless legs syndrome maps on chromosome 14q","volume":"126","author":"Bonati","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.chest.2020.03.035_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mds.21254","article-title":"Family-based association study of the restless legs syndrome loci 2 and 3 in a European population","volume":"22","author":"Kemlink","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/01.wnl.0000233991.20410.b6","article-title":"A\u00a0novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13","volume":"67","author":"Levchenko","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10048-007-0113-1","article-title":"Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13","volume":"9","author":"Kemlink","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.chest.2020.03.035_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mds.22263","article-title":"Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1","volume":"24","author":"Levchenko","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000117","article-title":"An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment","volume":"27","author":"Garcia-Borreguero","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"10.1016\/j.chest.2020.03.035_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/brain\/awr012","article-title":"Profile of altered brain iron acquisition in restless legs syndrome","volume":"134","author":"Connor","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.chest.2020.03.035_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome","volume":"14","author":"Mizuno","year":"2005","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.chest.2020.03.035_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.sleep.2016.05.001","article-title":"Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla","volume":"22","author":"Li","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sleep.2017.11.1126","article-title":"Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis-Ekbom disease in adults and children: an IRLSSG task force report","volume":"41","author":"Allen","year":"2018","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.chest.2020.03.035_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsmc.2015.05.022","article-title":"Restless leg syndrome\/Willis-Ekbom disease pathophysiology","volume":"10","author":"Allen","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.chest.2020.03.035_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1389-9457(00)00025-3","article-title":"Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(06)70576-2","article-title":"Less is more: pathophysiology of dopaminergic- therapy-related augmentation in restless legs syndrome","volume":"5","author":"Paulus","year":"2006","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.chest.2020.03.035_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2016.09.002","article-title":"Adenosine receptors as markers of brain iron deficiency: implications for restless legs syndrome","volume":"111","author":"Quiroz","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.chest.2020.03.035_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109636","article-title":"Characterization of A11 neurons projecting to the spinal cord of mice","volume":"9","author":"Koblinger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2020.03.035_bib37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q","article-title":"Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome","volume":"15","author":"Ondo","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuroscience.2017.02.042","article-title":"Aging-related morphine tolerance in dopamine D3 receptor knockout mice reversed by block of D1 receptor function","volume":"349","author":"Samir","year":"2017","journal-title":"Neuroscience"},{"issue":"22","key":"10.1016\/j.chest.2020.03.035_bib39","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1212\/WNL.0b013e318294b3f6","article-title":"Thalamic glutamate\/glutamine in restless legs syndrome: increased and related to disturbed sleep","volume":"80","author":"Allen","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.chest.2020.03.035_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858418791763","article-title":"New insights into the neurobiology of restless legs syndrome","volume":"25","author":"Ferr\u00e9","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.chest.2020.03.035_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sleep.2018.02.002","article-title":"Treatment of restless legs syndrome\/Willis-Ekbom disease with the non-selective ENT1\/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis","volume":"45","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.sleep.2011.11.020","article-title":"Descriptors of restless legs syndrome & sensations","volume":"13","author":"Kerr","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/sleep\/22.7.901","article-title":"Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome","volume":"22","author":"Hening","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2020.03.035_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sleep.2007.11.024","article-title":"Evaluating daytime alertness in individuals with restless legs syndrome (RLS) compared to sleep restricted controls","volume":"10","author":"Gamaldo","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.sleep.2010.03.016","article-title":"Development of the pediatric restless legs syndrome severity scale (P-RLS-SS): a patient-reported outcome measure of pediatric RLS symptoms and impact","volume":"11","author":"Arbuckle","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"International Restless Legs Syndrome Study Group: Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria: history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mds.870130220","article-title":"Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome","volume":"13","author":"Montplaisir","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.10.010","article-title":"World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)","volume":"26","author":"Ferri","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/sleep\/33.3.287","article-title":"Evidence continues to mount on the relationship of restless legs syndrome\/ periodic limb movements in sleep to hypertension, cardiovascular disease, and stroke","volume":"33","author":"Walters","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2020.03.035_bib50","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/mds.20969","article-title":"Validation of the \u201cL-DOPA test\u201d for diagnosis of restless legs syndrome","volume":"21","author":"Stiasny-Kolster","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.5665\/sleep.2820","article-title":"Validation of the multiple suggested immobilization test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease)","volume":"36","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2020.03.035_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2015.11.018","article-title":"Diagnostic accuracy of the standard and alternative periodic leg movement during sleep indices for restless legs syndrome","volume":"22","author":"Ferri","year":"2016","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.chest.2020.03.035_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jsmc.2015.05.021","article-title":"Differential diagnoses of restless legs syndrome\/Willis-Ekbom disease: mimics and comorbidities","volume":"10","author":"Chokroverty","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.chest.2020.03.035_bib55","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.0000000000002542","article-title":"Restless legs syndrome associated with major diseases: a systematic review and new concept","volume":"86","author":"Trenkwalder","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib56","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jsr.12040","article-title":"A\u00a0time sequence analysis of the relationship between cardiovascular risk factors, vascular diseases and restless legs syndrome in the general population","volume":"22","author":"Szentkiralyi","year":"2013","journal-title":"J\u00a0Sleep Res"},{"issue":"15","key":"10.1016\/j.chest.2020.03.035_bib57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/01.wnl.0000259036.89411.52","article-title":"Nocturnal blood pressure changes in patients with restless legs syndrome","volume":"68","author":"Pennestri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sleep.2016.05.014","article-title":"Periodic leg movements during sleep: phenotype, neurophysiology and clinical significance","volume":"31","author":"Ferri","year":"2017","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.chest.2020.03.035_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/01.wnl.0000287072.93277.c9","article-title":"Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study","volume":"70","author":"Winkelman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/NDT.S19177","article-title":"Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome","volume":"7","author":"Mitchell","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"Suppl 3","key":"10.1016\/j.chest.2020.03.035_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2006.01586.x","article-title":"Considering the causes of RLS","volume":"13","author":"Winkelman","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNF.0b013e3182087d48","article-title":"A\u00a052-week study of gabapentin enacarbil in restless legs syndrome","volume":"34","author":"Ellenbogen","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.chest.2020.03.035_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","article-title":"Efficacy and augmentation during 6\u00a0months of double-blind pramipexole for restless legs syndrome","volume":"12","author":"Ho\u00a8gl","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4065\/81.1.17","article-title":"Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bogan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.chest.2020.03.035_bib66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(08)70112-1","article-title":"SP790 Study Group: Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Trenkwalder","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib67","author":"Allen","year":"2012"},{"key":"10.1016\/j.chest.2020.03.035_bib68","first-page":"927","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12\u00a0week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.chest.2020.03.035_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.sleep.2011.09.016","article-title":"Augmentation in the treatment of restless legs syndrome with transdermal rotigotine","volume":"13","author":"Benes","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib70","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.0b013e3181e1ce73","article-title":"Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study","volume":"74","author":"Garcia-Borreguero","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.chest.2020.03.035_bib71","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4065\/mcp.2009.0700","article-title":"Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study","volume":"85","author":"Bogan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.chest.2020.03.035_bib72","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","article-title":"Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension","volume":"12","author":"Trenkwalder","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.chest.2020.03.035_bib73","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.20359","article-title":"Methadone for refractory restless legs syndrome","volume":"20","author":"Ondo","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2020.03.035_bib74","first-page":"CD006939","article-title":"Benzodiazepines for restless legs syndrome","volume":"3","author":"Carlos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.chest.2020.03.035_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574884708666131111202954","article-title":"Drug-induced impulse control disorders: a review","volume":"9","author":"Atmaca","year":"2014","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.chest.2020.03.035_bib76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2020.03.035_bib77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.sleep.2007.03.022","article-title":"Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute","volume":"8","author":"Garc\u00eda-Borreguero","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.smrv.2018.01.001","article-title":"Management of treatment failure in restless legs syndrome (Willis-Ekbom disease)","volume":"41","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.chest.2020.03.035_bib79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.08.019","article-title":"In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine","volume":"31","author":"Ferr\u00e9","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.03.035_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2017.03.012","article-title":"Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel","volume":"34","author":"Garcia-Borreguero","year":"2017","journal-title":"Sleep Med"},{"issue":"13","key":"10.1016\/j.chest.2020.03.035_bib81","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.4103\/0366-6999.159344","article-title":"Repetitive transcranial magnetic stimulation for the treatment of restless legs syndrome","volume":"128","author":"Lin","year":"2015","journal-title":"Chin Med J (Engl)"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220305663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220305663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:21:35Z","timestamp":1757924495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220305663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0012369220305663"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.03.035","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}